These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
538 related articles for article (PubMed ID: 15472346)
21. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients. Ruchlemer R; Yinnon AM; Hershko C Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078 [TBL] [Abstract][Full Text] [Related]
22. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin. Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935 [TBL] [Abstract][Full Text] [Related]
23. [The value of surgery in the treatment of invasive pulmonary aspergillosis in neutropenic patients]. Bernard A; Caillot D; Casasnovas O; Couaillier JF; Guy H; Favre JP Rev Mal Respir; 1998 Feb; 15(1):49-55. PubMed ID: 9551514 [TBL] [Abstract][Full Text] [Related]
25. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis. Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816 [No Abstract] [Full Text] [Related]
26. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ; Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256 [TBL] [Abstract][Full Text] [Related]
27. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Oren I; Haddad N; Finkelstein R; Rowe JM Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636 [TBL] [Abstract][Full Text] [Related]
28. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928 [TBL] [Abstract][Full Text] [Related]
29. Surgical resection for successful treatment of invasive pulmonary aspergillosis: report of 3 cases. Metin KS; Ugurlu BS; Kabakci B; Sariosmanoglu NO; Hazan E; Oto O Scand J Infect Dis; 2005; 37(9):694-6. PubMed ID: 16126574 [TBL] [Abstract][Full Text] [Related]
30. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model. Chandrasekar PH; Cutright J; Manavathu E J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091 [TBL] [Abstract][Full Text] [Related]
32. [Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient]. Hashimoto M; Honda Y; Fujishima T Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):957-61. PubMed ID: 18186242 [TBL] [Abstract][Full Text] [Related]
34. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Muñoz P; Marín M; Tornero P; Martín Rabadán P; Rodríguez-Creixéms M; Bouza E Clin Infect Dis; 2000 Dec; 31(6):1499-501. PubMed ID: 11096022 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain]. Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM; Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037 [TBL] [Abstract][Full Text] [Related]
36. A novel cause of invasive pulmonary infection in an immunocompetent patient: Aspergillus candidus. Ribeiro SC; Santana AN; Arriagada GH; Martins JE; Takagaki TY J Infect; 2005 Nov; 51(4):e195-7. PubMed ID: 16291268 [TBL] [Abstract][Full Text] [Related]
37. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight. Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222 [TBL] [Abstract][Full Text] [Related]
38. Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole. Wandroo F; Stableforth P; Hasan Y Clin Lab Haematol; 2006 Apr; 28(2):130-3. PubMed ID: 16630219 [TBL] [Abstract][Full Text] [Related]
39. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation. Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389 [TBL] [Abstract][Full Text] [Related]
40. Disseminated invasive aspergillosis in an apparently immunocompetent host. Raja NS; Singh NN J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]